Sanofi strikes deal for US rights to Roche Tamiflu Medical Dialogues Bureau24 July 2019 9:15 AM ISTUnder the terms of the agreement, Sanofi will be responsible for leading FDA negotiations for the OTC switch and subsequent exclusive marketing,...
Laurus Labs, Rising Pharma launches neuropathic pain capsules in US Medical Dialogues Bureau23 July 2019 9:30 AM ISTRising Pharmaceuticals has launched a generic version of Lyrica capsules, in the strengths of 25 mg, 50 mg, 75 mg, 100 mg, 150 mg, 200 mg, 225 mg and...
Delhi HC restricts Lee Pharma from infringing copyright of Mankind Pharma Medical Dialogues Bureau21 July 2019 4:30 PM ISTJustice Prathiba M Singh said considering the evidence and the content of the website of Lee Pharmaceuticals of Lee House being identical, a permanent...
Zydus Cadila arm gets USFDA nod for generic version of Adderall XR capsules in US Medical Dialogues Bureau21 July 2019 10:00 AM ISTThe product is a generic version of Adderall XR capsules and will be manufactured at Nesher Pharmaceuticals' manufacturing facility at St Louis in the...
USFDA to review Sanofi isatuximab for treatment of multiple myeloma Medical Dialogues Bureau21 July 2019 9:15 AM ISTSanofi Isatuximab targets a specific epitope on the CD38 receptor. It is designed to trigger multiple, distinct mechanisms of action that are believed...
Strides Pharma found destroying, dumping drug production documents: USFDA Investigation Medical Dialogues Bureau20 July 2019 2:16 PM ISTIn the letter to Strides Pharma, the FDA didn't explain whether its inspectors often check scrap yards or shredding rooms for documents, or whether it...
Dr Reddys unveils generic version of Allegra D in US to treat common cold, flu Medical Dialogues Bureau20 July 2019 11:37 AM ISTIn a BSE filing, Dr Reddy's Labs(Dr Reddys) announced "launch of Fexofenadine HCI 60 mg and Pseudoephedrine HCI 120 mg extended-release tablets, USP,...
Novartis CEO sets aside 700 Million Dollar to settle doctor bribery lawsuit Medical Dialogues Bureau20 July 2019 9:52 AM ISTZURICH: Novartis Chief Executive Vas Narasimhan set aside $700 million to settle a U.S. doctor bribery lawsuit, as the Swiss drugmaker seeks to close...
Cabinet Nod to Rs 330 crore loan to 3 pharma PSUs for clearing staff liabilities Medical Dialogues Bureau19 July 2019 3:03 PM ISTNEW DELHI: The Union Cabinet Wednesday approved loans of Rs 330.35 crore to three state-owned pharma companies to help them clear employees'...
Abbott hits record high as blood sugar monitoring device- FreeStyle Libre 2 fuels profit Medical Dialogues Bureau19 July 2019 3:02 PM ISTAbbott Laboratories beat analysts' estimates for quarterly profit and lifted its full-year earnings forecast on Wednesday, boosted by a near 64% jump...
Patients with NASH have been enrolled in 3 phase III trials of Saroglitazar, says Zydus Cadila Medical Dialogues Bureau18 July 2019 9:17 AM IST"Patients with NASH have been enrolled in these trials across clinical sites in India and Mexico," Cadila Healthcare, the listed entity of the group,...
Novartis sickle cell drug crizanlizumab secures speedy USFDA review Medical Dialogues Bureau17 July 2019 9:26 AM ISTNovartis submitted the application for crizanlizumab for the prevention of vaso-occlusive crises (VOCs) in patients with sickle cell disease (SCD) and...
